Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Income from Continuing Operations: 2018-2025

Historic Income from Continuing Operations for Neurogene (NGNE) over the last 4 years, with Sep 2025 value amounting to -$21.1 million.

  • Neurogene's Income from Continuing Operations fell 3.65% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 23.93%. This contributed to the annual value of -$75.7 million for FY2024, which is 43.76% down from last year.
  • Per Neurogene's latest filing, its Income from Continuing Operations stood at -$21.1 million for Q3 2025, which was up 9.15% from -$23.2 million recorded in Q2 2025.
  • Neurogene's Income from Continuing Operations' 5-year high stood at -$11.9 million during Q2 2023, with a 5-year trough of -$23.2 million in Q2 2025.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$18.6 million (2024), whereas its average is -$17.8 million.
  • Data for Neurogene's Income from Continuing Operations shows a maximum YoY slumped of 57.14% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Neurogene's Income from Continuing Operations stood at -$14.0 million in 2023, then tumbled by 40.71% to -$19.7 million in 2024, then dropped by 3.65% to -$21.1 million in 2025.
  • Its Income from Continuing Operations was -$21.1 million in Q3 2025, compared to -$23.2 million in Q2 2025 and -$22.8 million in Q1 2025.